- Home
- CSBR vs JLS Comparison
CSBR vs JLS Comparison
Compare CSBR & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- JLS
- Stock Information
- Founded
- CSBR 1985
- JLS 2009
- Country
- CSBR United States
- JLS United States
- Employees
- CSBR N/A
- JLS N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- JLS Investment Managers
- Sector
- CSBR Health Care
- JLS Finance
- Exchange
- CSBR Nasdaq
- JLS Nasdaq
- Market Cap
- CSBR 123.2M
- JLS 103.4M
- IPO Year
- CSBR 1986
- JLS N/A
- Fundamental
- Price
- CSBR $6.75
- JLS $18.97
- Analyst Decision
- CSBR Strong Buy
- JLS
- Analyst Count
- CSBR 1
- JLS 0
- Target Price
- CSBR $12.00
- JLS N/A
- AVG Volume (30 Days)
- CSBR 39.7K
- JLS 26.6K
- Earning Date
- CSBR 09-10-2025
- JLS 01-01-0001
- Dividend Yield
- CSBR N/A
- JLS 9.33%
- EPS Growth
- CSBR N/A
- JLS N/A
- EPS
- CSBR 0.33
- JLS N/A
- Revenue
- CSBR $56,944,000.00
- JLS N/A
- Revenue This Year
- CSBR $9.30
- JLS N/A
- Revenue Next Year
- CSBR $31.17
- JLS N/A
- P/E Ratio
- CSBR $19.52
- JLS N/A
- Revenue Growth
- CSBR 13.54
- JLS N/A
- 52 Week Low
- CSBR $3.60
- JLS $15.48
- 52 Week High
- CSBR $11.99
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- CSBR 41.70
- JLS 54.28
- Support Level
- CSBR $5.85
- JLS $18.63
- Resistance Level
- CSBR $6.74
- JLS $19.02
- Average True Range (ATR)
- CSBR 0.54
- JLS 0.14
- MACD
- CSBR -0.14
- JLS -0.02
- Stochastic Oscillator
- CSBR 26.08
- JLS 53.49
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.